natgillin/translations-raw huggingface dataset:
Children weighing > 40 kg and who are able to swallow capsules may receive treatment with the adult dosage of 75 mg capsules twice daily for 5 days as an alternative to the recommended dose of Tamiflu suspension. 
Djeca tjelesne težine > 40 kg koja mogu progutati kapsule, umjesto preporučene doze Tamiflu suspenzije također mogu dobivati terapijsku dozu u obliku kapsule od 75 mg dvaput dnevno tijekom 5 dana.
• If you have the right capsule strength for the dose needed (a 75 mg dose), you will open the capsule and stir its contents into one teaspoon (or less) of a suitable sweetened food product. 
• Ako imate odgovarajuću kapsulu za dozu koja je potrebna (dozu od 75 mg), otvorit ćete kapsulu i njezin sadržaj umiješati u jednu čajnu žličicu (ili manje) prikladne slatke hrane.
The recommended dose is based on the patient's body weight.You must use the amount of oral capsules or suspension prescribed by the doctor. 
Morate uzimati onu količinu kapsula ili oralne suspenzije koju je propisao liječnik.
• The other ingredients are: capsule contents: pregelatinised starch, talc, povidone, croscarmellose sodium and sodium stearyl fumarate capsule shell: gelatin, black iron oxide (E172) and titanium dioxide (E171) printing ink: shellac (E904), titanium dioxide (E171) and FD and C Blue 2 (indigo carmine E132). 
• Drugi sastojci su: Sadržaj kapsule: škrob (kukuruzni) prethodno geliran, talk, povidon, umrežena karmelozanatrij i natrijev stearilfumarat Ovojnica kapsule: želatina, crni željezov oksid (E172) i titanijev dioksid (E171) Tinta: šelak (E904), titanijev dioksid (E171) i boja „FDiC Blue 2“ (indigo karmin, E132).
Detailed information on this medicinal product is available on the website of the European Medicines Agency http://www.ema.europa.eu 
Ova uputa je zadnji puta revidirana u {MM/GGGG} Detaljne informacije o ovom lijeku dostupne su na internetskoj stranici Europske agencije za lijekove: http://www.ema.europa.eu
Push the plunger completely down toward the tip of the dispenser. 
Gurnite klip do kraja u smijeru vrha štrcaljke.
Step 3: Sweeten the powder and give the dose Add a small amount - no more than one teaspoonful - of sweet food to the powder in the bowl. 
Dodajte malu količinu - ne više od jedne čajne žličice - slatke hrane u zdjelicu s prahom.
For dosing, a 3 ml and 10 ml oral dispenser is provided in the box. 
U kutiji je priložena štrcaljka za usta od 3 ml i 10 ml koja služi za primjenu doze lijeka.
INFORMATION IN BRAILLE tamiflu 75 mg 
tamiflu 75 mg
9 mg once daily 
9 mg jednom dnevno
15 mg once daily 
15 mg jednom dnevno
• One 30 mg Tamiflu capsule 
• jedna Tamiflu kapsula od 30 mg
4 kg 12 mg 2.0 ml 
12 mg 2,0 ml
In the total population, there was a reduction in the incidence of laboratory-confirmed clinical influenza in households from 20 % (27/136) in the group not receiving prevention to 7 % (10/135) in the group receiving prevention (62.7 % reduction [95 % CI 26.0 - 81.2; p = 0.0042]). 
U ukupnoj populaciji došlo je do smanjenja incidencije laboratorijski potvrđene i klinički izražene gripe u kućanstvima: od 20 % (27/136) u skupini u kojoj nije provedena prevencija, na 7 % (10/135) u skupini u kojoj je prevencija provedena (smanjenje od 62,7 %, [95 % CI 26,0 - 81,2; p= 0,0042]).
12.5 ml twice daily 12.5 ml once daily 
12,5 ml dvaput dnevno 12,5 ml jednom dnevno
• One 75 mg Tamiflu capsule 
• jedna Tamiflu kapsula od 75 mg
Prevention of influenza: Dose adjustment is recommended for adults and adolescents (13 to 17 years of age) with moderate or severe renal impairment as detailed in the table below. 
Prevencija gripe: U odraslih i adolescenata (u dobi od 13 do 17 godina) s umjerenim ili teškim oštećenjem bubrežne funkcije preporučuje se prilagodba doze, prema sljedećoj tablici.
18 mg twice daily 
18 mg dvaput dnevno
See leaflet for further information. 
Za dodatne informacije pročitajte uputu o lijeku
PHARMACEUTICAL FORM AND CONTENTS 1 bottle 
OBLIK I SADRŽAJ
No dose adjustment is required either for treatment or for prevention in patients with hepatic dysfunction. 
U bolesnika s oštećenjem jetrene funkcije nije potrebno prilagođavati dozu ni za liječenje ni za prevenciju.
1.8 ml twice daily 1.8 ml once daily 2.0 ml or 3.0 ml 
1,8 ml dvaput dnevno 1,8 ml jednom dnevno 2,0 ml ili 3,0 ml
INFORMATION IN BRAILLE tamiflu 45 mg 
tamiflu 45 mg
More than 15 kg, up to 23 kg 
Više od 15 kg i do 23 kg
1.5 ml twice daily 1.5 ml once daily 2.0 ml or 3.0 ml 
1,5 ml dvaput dnevno 1,5 ml jednom dnevno 2,0 ml ili 3,0 ml
Black iron oxide (E172) Titanium dioxide (E171) 
Ovojnica kapsule želatina željezov oksid, crni (E172) titanijev dioksid (E171)
Tamiflu 30 mg hard capsules 
Tamiflu 30 mg tvrde kapsule
9 mg twice daily 
9 mg dvaput dnevno
• One or two 30 mg Tamiflu capsule(s) 
• jedna ili dvije Tamiflu kapsule od 30 mg
24 mg once daily 
24 mg jednom dnevno
Tamiflu 75 mg hard capsules 
Tamiflu 75 mg tvrde kapsule
12 mg once daily 
12 mg jednom dnevno
> 9 to 10 kg 
>9 do 10 kg
27 mg once daily 
27 mg jednom dnevno
More than 23 kg, up to 40 kg 
Više od 23 kg i do 40 kg
10 ml twice daily 
10 ml dvaput dnevno
The hard capsule consists of a grey opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “75 mg”. 
Tvrda kapsula se sastoji od sivog neprozirnog tijela s natpisom "ROCHE" i svjetložute neprozirne kapice s natpisom "75 mg".
Tutti frutti flavour (including maltodextrins [maize], propylene glycol, arabic gum E414 and natural identical flavouring substances [mainly consisting of banana, pineapple and peach flavour]). 
natrijev benzoat (E211), saharinnatrij (E954), titanijev dioksid (E171) i voćna aroma (koja sadrži maltodekstrin [kukuruzni škrob], propilenglikol, arapsku gumu E414 i prirodno identične okuse [koji se uglavnom sastoje od banane, ananasa i breskve]).
• One 45 mg Tamiflu capsule 
• jedna Tamiflu kapsula od 45 mg
7.5 ml oseltamivir suspension delivers 1.3 g of sorbitol. 
7,5 ml oseltamivir suspenzije sadrži 1,3 g sorbitola. 10 ml oseltamivir suspenzije sadrži 1,7 g sorbitola.
10 ml once daily 
10 ml jednom dnevno
Dosing chart for pharmacy compounded 6 mg/ml suspension prepared from Tamiflu capsules for infants less than 1 year of age 
Tablica doziranja za suspenziju koncentracije 6 mg/ml pripremljenu iz Tamiflu kapsula u ljekarni, za dojenčad mlađu od 1 godine Tjelesna težina (zaokružena na najbližih 0,5 kg)
Dose of Tamiflu Number of capsules 
Doza lijeka Tamiflu Količina Tamiflu mješavine
The hard capsule consists of a grey opaque body bearing the imprint “ROCHE” and a grey opaque cap bearing the imprint “45 mg”. 
Tvrda kapsula se sastoji od sivog neprozirnog tijela s natpisom "ROCHE" i sive neprozirne kapice s natpisom "45 mg".
Severe renal impairment 
Teška popratna medicinska stanja
No studies have been carried out in paediatric patients with hepatic disorder. 
U djece s poremećajem jetrene funkcije nisu provedena ispitivanja.
15 mg twice daily 
15 mg dvaput dnevno
Tamiflu 30 mg, 45 mg and 75 mg capsules and oral suspension are available for infants and children 1 year of age or older 
Za dojenčad i djecu u dobi od 1 godine ili stariju na raspolaganju su Tamiflu 30 mg, 45 mg i 75 mg kapsule i oralna suspenzija.
• Delusions, hallucinations, agitation, anxiety, nightmares These are reported primarily among children and adolescents and often started suddenly and resolved rapidly. 
Ovi su događaji prijavljeni prvenstveno u djece i adolescenata i često su iznenada počinjali i brzo prestajali.
upper abdominal pain), Dyspepsia, Nausea 
Poremećaji probavnog sustava povraćanje bol u abdomenu (uključujući bol u gornjem dijelu abdomena), dispepsija, mučnina
Use the larger dispenser to draw up 5 ml water. 
U prvu štrcaljku navucite 5 ml vode.
Stage 2: Measure and give the correct dose 
3. korak: Zasladite prah i dajte dozu
> 8 to 9 kg 
>8 do 9 kg
B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE Medicinal product subject to medical prescription 
UVJETI ILI OGRANIČENJA VEZANA UZ OPSKRBU I PRIMJENU
Treatment of influenza: Dose adjustment is recommended for adults and adolescents (13 to 17 years of age) with moderate or severe renal impairment. 
Liječenje gripe: U odraslih i adolescenata (u dobi od 13 do 17 godina) s umjerenim ili teškim oštećenjem bubrežne funkcije preporučuje se prilagodba doze.
24 mg twice daily 
24 mg dvaput dnevno
12.5 ml once daily 
12,5 ml jednom dnevno
> 6 to 7 kg 
>6 do 7 kg
Yellow iron oxide (E172) Red iron oxide (E172) Titanium dioxide (E171) 
Ovojnica kapsule želatina željezov oksid, žuti (E172) željezov oksid, crveni (E172) titanijev dioksid (E171)
1.8 ml twice daily 1.8 ml once daily 3 ml 
1,8 ml dvaput dnevno 1,8 ml jednom dnevno 3 ml
> 7 to 8 kg 
>7 do 8 kg
Tamiflu 30 mg hard capsules oseltamivir 
Tamiflu 30 mg tvrde kapsule oseltamivir
Adults and adolescents 13 and over 
Odrasli i adolescenti
Tamiflu 30 mg and 45 mg capsules are available as an alternative to the recommended dose of Tamiflu 6 mg/ml suspension. 
Umjesto preporučene doze Tamiflu 6 mg/ml suspenzije na raspolaganju su također Tamiflu 30 mg i 45 mg kapsule.
21 mg once daily 
21 mg jednom dnevno
A 3 ml oral dispenser (graduated in 0.1 ml steps) should be used for dosing infants less than 1 year old requiring 1 to 3 ml of Tamiflu oral suspension. 
Za davanje lijeka dojenčadi mlađoj od 1 godine koja trebaju 1 do 3 ml Tamiflu oralne suspenzije moraju se koristiti štrcaljke za usta od 3 ml (s oznakama po 0,1 ml).
7.5 ml once daily 
7,5 ml jednom dnevno
Post-exposure prevention of influenza in infants less than 1 year of age during a pandemic: Prevention during an influenza pandemic has not been studied in controlled clinical studies in children 0-12 months of age. 
Prevencija tijekom pandemije gripe nije ispitivana u kontroliranim kliničkim ispitivanjima u djece u dobi od 0-12 mjeseci.
Yellow iron oxide (E172) Red iron oxide (E172) Black iron oxide (E172) Titanium dioxide (E171) 
Ovojnica kapsule želatina željezov oksid, žuti (E172) željezov oksid, crveni (E172) željezov oksid, crni (E172) titanijev dioksid (E171)
1.5 ml twice daily 1.5 ml once daily 3 ml 
1,5 ml dvaput dnevno 1,5 ml jednom dnevno 3 ml
10.0 ml twice daily 10.0 ml once daily 
10,0 ml dvaput dnevno 10,0 ml jednom dnevno
Powder: Do not store above 30 ºC Oral suspension: Store below 25 °C for 10 days 
Oralna suspenzija: Čuvati 10 dana na temperaturi ispod 25 °C
Tamiflu 45 mg hard capsules 
Tamiflu 45 mg tvrde kapsule
27 mg twice daily 
27 mg dvaput dnevno
Tamiflu 75 mg hard capsules oseltamivir 
Tamiflu 75 mg tvrde kapsule oseltamivir
Tamiflu 45 mg hard capsules oseltamivir 
Tamiflu 45 mg tvrde kapsule oseltamivir
The hard capsule consists of a light yellow opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “30 mg”. 
Tvrda kapsula se sastoji od svjetložutog neprozirnog tijela s natpisom "ROCHE" i svijetložute neprozirne kapice s natpisom "30 mg".
Push the tip of the dispenser into the bottle adapter. 
Umetnite vrh štrcaljke u nastavak za bocu.
5 ml twice daily 
5 ml dvaput dnevno
Body weight Recommended dose for 10 days Amount of oral suspension to withdraw 10 kg to 15 kg 
Preporučene su sljedeće terapijske doze za dojenčad i djecu u dobi od 1 godine i stariju, prilagođene tjelesnoj težini: Tjelesna težina Preporučena doza tijekom 5 dana Potrebna količina suspenzije 10 kg do 15 kg
3.0 ml once daily 
3,0 ml jednom dnevno
Fertility 
sinusitis
4.0 ml twice daily 4.0 ml once daily 10 ml 
4,0 ml dvaput dnevno 4,0 ml jednom dnevno 10 ml
• Each hard capsule contains oseltamivir equivalent to 30 mg of oseltamivir 
• Jedna tvrda kapsula sadrži oseltamivirfosfat koji odgovara 30 mg oseltamivira
Posology and method of administration) results in an increased exposure (of up to 50%) to the active metabolite when compared to adult nonimmunocompromised patients with comparable creatinine clearance. 
Populacijska farmakokinetička analiza ukazuje na to da liječenje oseltamivirom u odraslih imunokompromitiranih bolesnika (kako je opisano u dijelu 4.2 Doziranje i način primjene) dovodi do povećane razine izloženosti (do 50%) aktivnom metabolitu u odnosu na odrasle bolesnike koji nisu imunokompromitirani, uz usporediv klirens kreatinina.
75 mg can be made up of a 30 mg capsule plus a 45 mg capsule Children 1 to 12 years 
75 mg jednom dnevno 75 mg se može dobiti uzimanjem jedne kapsule od 30 mg i jedne kapsule od 45 mg
12 mg twice daily 
12 mg dvaput dnevno
STATEMENT OF ACTIVE SUBSTANCE(S) Each hard capsule contains oseltamivir phosphate equivalent to 30 mg of oseltamivir. 
NAVOĐENJE DJELATNE(IH) TVARI Svaka tvrda kapsula sadržava oseltamivirfosfat, koji odgovara 30 mg oseltamivira
5 ml once daily 
5 ml jednom dnevno
3.5 ml twice daily 3.5 ml once daily 10 ml 
3,5 ml dvaput dnevno 3,5 ml jednom dnevno 10 ml
• Each hard capsule contains oseltamivir equivalent to 45 mg of oseltamivir 
• Jedna tvrda kapsula sadrži oseltamivirfosfat koji odgovara 45 mg oseltamivira
Patients with Resistance Mutations (%) Phenotyping* Geno- and Phenotyping* Adults and adolescents 0.88% (21/2377) 
Bolesnici s mutacijama odgovornima za rezistenciju (%) Fenotipizacija*
The recommended post-exposure prevention dose of Tamiflu is: 
Preporučena preventivna doza lijeka Tamiflu nakon izloženosti virusu iznosi: Tjelesna težina
STATEMENT OF ACTIVE SUBSTANCE(S) Each hard capsule contains oseltamivir phosphate equivalent to 75 mg of oseltamivir. 
NAVOĐENJE DJELATNE(IH) TVARI Svaka tvrda kapsula sadržava oseltamivirfosfat, koji odgovara 75 mg oseltamivira
3.0 ml twice daily 3.0 ml once daily 3 ml 
3,0 ml dvaput dnevno 3,0 ml jednom dnevno 3 ml
The NNT in this study was 25 (95 % CI 23 
Broj osoba koje je bilo potrebno liječiti da bi se spriječio jedan slučaj gripe (NNT) u tom je ispitivanju bio 25 (95 % CI 23 - 62).
12.5 ml twice daily 
12,5 ml dvaput dnevno
• The bottle cap (in the medicine pack) 
• zatvarač boce (u pakiranju lijeka)
STATEMENT OF ACTIVE SUBSTANCE(S) Each hard capsule contains oseltamivir phosphate equivalent to 45 mg of oseltamivir. 
NAVOĐENJE DJELATNE(IH) TVARI Svaka tvrda kapsula sadržava oseltamivirfosfat, koji odgovara 45 mg oseltamivira
2.8 ml twice daily 2.8 ml once daily 3 ml 
2,8 ml dvaput dnevno 2,8 ml jednom dnevno 3 ml
7.5 ml twice daily 
7,5 ml dvaput dnevno
21 mg twice daily 
21 mg dvaput dnevno
3.5 ml once daily 
3,5 ml jednom dnevno
4.0 ml once daily 
4,0 ml jednom dnevno
Sodium dihydrogen citrate (E331[a]) 
• Drugi sastojci su: sorbitol (E420), natrijev dihidrogencitrat (E331[a]), ksantanska guma (E415),
2.5 ml twice daily 2.5 ml once daily 3 ml 
2,5 ml dvaput dnevno 2,5 ml jednom dnevno 3 ml
2.0 ml once daily 
2,0 ml jednom dnevno
NAME OF THE MEDICINAL PRODUCT Tamiflu 30 mg capsules Oseltamivir 
Tamiflu 30 mg kapsule oseltamivir
Dose of Tamiflu 
Tjelesna težina Doza lijeka Tamiflu
5.0 ml once daily 
5,0 ml jednom dnevno
5.0 ml twice daily 5.0 ml once daily 10 ml 
5,0 ml dvaput dnevno 5,0 ml jednom dnevno 10 ml
• The other ingredients are: capsule contents: pregelatinised starch, talc, povidone, croscarmellose sodium and sodium stearyl fumarate capsule shell: gelatin, yellow iron oxide (E172), red iron oxide (E172), black iron oxide (E172) and titanium dioxide (E171) printing ink: shellac (E904), titanium dioxide (E171) FD and C Blue 2 (indigo carmine E132). 
Ovojnica kapsule: želatina, žuti željezov oksid (E172), crveni željezov oksid (E172), crni željezov oksid (E172) i titanijev dioksid (E171) Tinta: šelak (E904), titanijev dioksid (E171) i boja „FDiC Blue 2“ (indigo karmin, E132).
What Tamiflu looks like and contents of the pack The 75 mg hard capsule consists of a grey opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “75 mg”. 
Tvrda kapsula od 75 mg se sastoji od sivog neprozirnog tijela s natpisom "ROCHE" i svijetložute neprozirne kapice s natpisom "75 mg".
3.0 ml twice daily 
3,0 ml dvaput dnevno
MARKETING AUTHORISATION NUMBER(S) EU/1/02/222/005 
BROJ ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/02/222/005
2.5 ml once daily 
2,5 ml jednom dnevno
2.3 ml twice daily 2.3 ml once daily 3 ml 
2,3 ml dvaput dnevno 2,3 ml jednom dnevno 3 ml
Adults and adolescents 13 years of age and older: Patients were eligible if they reported within 36 hours of onset of symptoms, had fever ≥ 37.8 °C, accompanied by at least one respiratory symptom (cough, nasal symptoms or sore throat) and at least one systemic symptom (myalgia, chills/sweats, malaise, fatigue or headache). 
C, koju je pratio barem jedan respiratorni simptom (kašalj, nazalni simptomi ili grlobolja) i barem jedan sustavni simptom (bol u mišićima, zimica/znojenje, opća slabost, umor ili glavobolja).
2.8 ml twice daily 2.8 ml once daily 
2,8 ml dvaput dnevno 2,8 ml jednom dnevno
Elevated liver enzymes 
Poremećaji jetre i žuči povišene razine jetrenih enzima fulminantni hepatitis,
What Tamiflu looks like and contents of the pack The 30 mg hard capsule consists of a light yellow opaque body bearing the imprint “ROCHE” and a light yellow opaque cap bearing the imprint “30 mg”. 
Tvrda kapsula od 30 mg se sastoji od svijetložutog neprozirnog tijela s natpisom "ROCHE" i svijetložute neprozirne kapice s natpisom "30 mg".
3.5ml twice daily 3.5 ml once daily 
3,5ml dvaput dnevno 3,5 ml jednom dnevno
30 mg dose 
doza od 30 mg doza od 60 mg
What Tamiflu looks like and contents of the pack The 45 mg hard capsule consists of a grey opaque body bearing the imprint “ROCHE” and a grey opaque cap bearing the imprint “45 mg”. 
Tvrda kapsula od 45 mg se sastoji od sivog neprozirnog tijela s natpisom "ROCHE" i sive neprozirne kapice s natpisom "45 mg".
1.5 ml once daily 
1,5 ml jednom dnevno
NAME OF THE MEDICINAL PRODUCT Tamiflu 75 mg capsules Oseltamivir 
Tamiflu 75 mg kapsule oseltamivir
2.0 ml twice daily 2.0 ml once daily 3 ml 
2,0 ml dvaput dnevno 2,0 ml jednom dnevno 3 ml
• Each hard capsule contains oseltamivir equivalent to 75 mg of oseltamivir 
• Jedna tvrda kapsula sadrži oseltamivirfosfat koji odgovara 75 mg oseltamivira.
Children 1 year or older, weighing less than 40 kg: 
Djeca u dobi od 1 godine ili starija, tjelesne težine manje od 40 kg: Doza lijeka Tamiflu
10.5 mg once daily 
10,5 mg jednom dnevno 1,8 ml jednom dnevno
Roche d.o.o Tel: +385 1 4722 333 
Roche farmacevtska družba d.o.o. Tel: +386 - 1 360 26 00
13.5 mg once daily 
13,5 mg jednom dnevno 2,3 ml jednom dnevno
Eczema, Dermatitis, Rash, Urticaria 
Poremećaji dišnog sustava, prsišta i sredoprsja kašalj, grlobolja, rinoreja
NAME OF THE MEDICINAL PRODUCT Tamiflu 45 mg capsules Oseltamivir 
Tamiflu 45 mg kapsule oseltamivir
4.5 ml twice daily 4.5 ml once daily 10 ml 
4,5 ml dvaput dnevno 4,5 ml jednom dnevno 10 ml
16.5 mg once daily 
16,5 mg jednom dnevno 2,8 ml jednom dnevno
2.0 ml twice daily 
2,0 ml dvaput dnevno
MARKETING AUTHORISATION NUMBER(S) EU/1/02/222/004 
12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/02/222/004
4.0 ml twice daily 
4,0 ml dvaput dnevno
MARKETING AUTHORISATION NUMBER(S) EU/1/02/222/001 
12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/02/222/001
Third, follow the procedure below for compounding the 6 mg/ml suspension from Tamiflu capsules: In a glass beaker of suitable size place the stated amount of water containing 0.05 % w/v sodium benzoate added as a preservative. 
U staklenu graduiranu čašu odgovarajuće veličine ulijte navedenu količinu vode s 0,05 % m/V natrijeva benzoata koji je dodan kao konzervans.
Capsule shell Gelatin 
Tamiflu kapsula.
1.5 ml twice daily 
1,5 ml dvaput dnevno
MARKETING AUTHORISATION NUMBER(S) EU/1/02/222/003 
12. BROJ(EVI) ODOBRENJA ZA STAVLJANJE LIJEKA U PROMET EU/1/02/222/003
3.5 ml twice daily 
3,5 ml dvaput dnevno
Posology and method of administration. 
OZNAČIVANJE I UPUTA O LIJEKU
20 October 2015 EMA/487922/2015 
EMA/487922/2015
After cooling, the essential oil separates from the water and can be collected. 
Nakon hlađenja, eterično ulje se odvaja iz vode i može se prikupiti.
A doctor or a qualified healthcare practitioner should be consulted if symptoms persist for more than one 
Potreban je savjet liječnika ili kvalificiranoga zdravstvenog djelatnika ako se simptomi nastave dulje od tjedan dana tijekom liječenja.
Patients with open wounds, extensive skin damage or acute (short-term) skin disease, high fever and severe infections should not have full or partial baths with matricaria oil. 
Bolesnici s otvorenim ranama, opsežnim oštećenjima kože ili akutnim (kratkotrajnim) kožnim bolestima, visokom vrućicom i teškim infekcijama ne smiju koristiti potpune ili djelomične kupke koje sadrže kamiličino eterično ulje.
Matricaria oil is the common name for the essential oil of the flower heads of the plant Matricaria recutita L. (also known as chamomile). 
Kamiličino eterično ulje je uobičajeni naziv za eterično ulje cvjetnih glavica biljke Matricaria recutita L. (također poznate pod nazivom kamilica).
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom week during treatment. 
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom20. listopada 2015. EMA/487922/2015
For detailed information on the studies assessed by the HMPC, see the HMPC assessment report. 
Za podrobnije informacije o ispitivanjima koje je HMPC ocijenio pogledajte izvješće HMPC-a o ocjeni lijeka.
Matricaria oil medicines should only be used in adults and adolescents (above 12 years of age). 
Lijekovi koji sadrže kamiličino eterično ulje smiju se koristiti samo u odraslih osoba i adolescenata (starijih od 12 godina).
Matricaria oil is obtained by a current of steam through the fresh or dried flowers or flowering tops of the plant. 
Kamiličino eterično ulje dobiva se protokom pare kroz svježe ili sušene cvjetove ili cvjetajuće vrhove biljke.
This summary is not intended to provide practical advice on how to use medicines containing matricaria oil. 
Svrha ovog sažetka nije pružanje praktičnih savjeta o načinu uporabe lijekova koji sadrže kamiličino eterično ulje.
Any applications for the licensing of medicines containing matricaria oil have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC. 
Svi zahtjevi za odobrenje lijekova koji sadrže kamiličino eterično ulje moraju se podnijeti nacionalnim tijelima nadležnim za lijekove, koja ocjenjuju zahtjev za biljni lijek i uzimaju u obzir znanstvene zaključke HMPC-a.
Further information on the risks associated with matricaria oil medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use. 
Više informacija o rizicima povezanim s lijekovima koji sadrže kamiličino eterično ulje, uključujući odgovarajuće mjere opreza za sigurnu uporabu, nalazi se u monografiji u rubrici „All documents” na internetskoj stranici Agencije: ema.europa.eu/Find medicine/Herbal medicines for human use.
Patients with severe heart and circulation problems should not have full baths with matricaria oil. 
Bolesnici s teškim problemima sa srcem ili cirkulacijom ne smiju koristiti potpune kupke s kamiličinim eteričnim uljem.
Matricaria oil can also be found in combination with other herbal substances in some herbal medicines. 
Kamiličino eterično ulje se može također naći i u kombinaciji s drugim biljnim tvarima u pojedinim biljnim lijekovima.
Information on the use and licensing of matricaria oil medicines in EU Member States should be obtained from the relevant national authorities. 
Informacije o uporabi i odobrenju lijekova koji sadrže kamiličino eterično ulje u državama članicama EU-a mogu se dobiti od nadležnih nacionalnih tijela.
The HMPC conclusions on the use of matricaria oil medicines for irritation of the skin and areas around anus and genitals are based on their ‘traditional use' in this condition. 
Zaključci HMPC-a o uporabi lijekova koji sadrže kamiličino eterično ulje za iritaciju kože i područja oko anusa i genitalija temelje se na „tradicionalnoj uporabi” kod tih stanja.